Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06634797
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-10-08
Brief Title:
A Study to Investigate Cardiac Troponin Levels After mRNA-1273712 Vaccine in Participants 12 Through 30 Years of Age
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase 4 Randomized Observer-blind Placebo-controlled Crossover Study to Assess Cardiac Troponin Levels After mRNA-1273712 Vaccine in Participants 12 Through 30 Years of Age
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary objective of this study is to assess cardiac troponin I cTnI values in participants who received mRNA-1273712 or placebo
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None